Accelerating Innovation In Precision Medicine The Focus Of New Harvard Business School Executive Education Program
Summary
The program breaks down the four priority areas that leaders in this field should focus on: direct-to-patient communications, data analysis, clinical trials, and investment and venture. The program curriculum provides senior leaders with an increased understanding of precision medicine by covering a broad range of issues related to the development, approval, and clinical use of targeted immunotherapies. Participants will learn how to better engage patients in their own care, leverage critical data and analytics, improve the design and performance of clinical trials, and collaborate with leaders from across industries. Health care leaders agree it is important that those who focus on cancer research and treatment partner more closely with patients – and with one another – to increase access to data and analytics. To that end, Accelerating Innovation in Precision Medicine takes an action-oriented approach to better understand key problems and solutions, with a goal of enabling participants to develop the best business models for targeted therapies in genetically-based diseases.